FDA Drug Application (202387) for SITAGLIPTIN PHOSPHATE by SANDOZ INC

Back to FDA Applications sponsored by SANDOZ INC

Application Number202387
Product Number001
FormTABLET; ORAL
DosageEQ 25MG BASE
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSITAGLIPTIN PHOSPHATE
Active IngredientSITAGLIPTIN PHOSPHATE

Active IngredientCount
List of drugs with Active Ingredient SITAGLIPTIN PHOSPHATE7


Back to FDA Applications sponsored by SANDOZ INC